Erratum: Detailed molecular fingerprinting of four new anaplastic thyroid carcinoma cell lines and their use for verification of RhoB as a molecular therapeutic target (Journal of Clinical Endocrinology and Metabolism (2010) 95 (5338-5347) DOI:10.1210/jc.2010-1421)

Laura A. Marlow, Jaclyn D'Innocenzi, Yilin Zhang, Stephen D. Rohl, Simon J. Cooper, Thomas Sebo, Clive Grant, Bryan McIver, Jan L. Kasperbauer, J. Trad Wadsworth, John D. Casler, Pamela W. Kennedy, W. Edward Highsmith, Orlo Clark, Dragana Milosevic, Brian Netzel, Kendall Cradic, Shilpi Arora, Christian Beaudry, Stefan K. GrebeMarc L. Silverberg, David O. Azorsa, Robert C. Smallridge, John A. Copland

Research output: Contribution to journalComment/debate

Original languageEnglish (US)
Number of pages1
JournalJournal of Clinical Endocrinology and Metabolism
Volume98
Issue number10
DOIs
StatePublished - Oct 1 2013

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Biochemistry
  • Endocrinology
  • Clinical Biochemistry
  • Biochemistry, medical

Cite this

Marlow, L. A., D'Innocenzi, J., Zhang, Y., Rohl, S. D., Cooper, S. J., Sebo, T., Grant, C., McIver, B., Kasperbauer, J. L., Wadsworth, J. T., Casler, J. D., Kennedy, P. W., Highsmith, W. E., Clark, O., Milosevic, D., Netzel, B., Cradic, K., Arora, S., Beaudry, C., ... Copland, J. A. (2013). Erratum: Detailed molecular fingerprinting of four new anaplastic thyroid carcinoma cell lines and their use for verification of RhoB as a molecular therapeutic target (Journal of Clinical Endocrinology and Metabolism (2010) 95 (5338-5347) DOI:10.1210/jc.2010-1421). Journal of Clinical Endocrinology and Metabolism, 98(10). https://doi.org/10.1210/jc.2013-3312